Abstract
Animal experiments offer a unique possibility to tailor study design and to standardize the experiment in a way that allows us to repeat challenges, monitoring and interventions according to scientific rationale. The animal models described in this chapter are thought to replicate human disorders where oxidative stress is a major component. These experimental settings are focused on inflammatory diseases, with particular focus on sepsis models, each animal model having its own advantages and disadvantages. Depending on the study rationale, it is possible to use specific animal models. In studies where the role of the genetic expression is thought to be evaluated, knockout mice are of utmost importance for the understanding of the synthesis of a functional gene product. When biological variables are used to determine and evaluate pathophysiological events, it is essential to know that the bioassay is applicable as well as knowledge to interpret detection limits and potential cross-reactions to other related compounds. Since inflammatory challenges differ between various types of animals, responses may not exactly reflect the reactions that occur in man. Species differences in both the innate immune systems, which offer immediate defense against infection in a nonspecific fashion, and the adaptive immune responses, which provide the vertebrate immune system with the capability to distinguish and recall identifiable pathogens are important limitations. Cascade systems and receptor expression are other examples where interpretative care must be taken. Nevertheless, animal models offer a unique possibility to study serious reactions and events, which are generally impossible to induce experimentally in man.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Redl H, Bahrami S, Schlag G, Traber DL. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993;187:330–45.
Michie HR. The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother 1998;41 Suppl A:47–9.
van Eijk LT, Pickkers P, Smits P, Bouw MP, van der Hoeven JG. Severe vagal response after endotoxin administration in humans. Intensive Care Med 2004;30:2279–81.
Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med 1993;328:1457–60.
Kuriyama T, Wagner Jr WW. Collateral ventilation may protect against high-altitude pulmonary hypertension. J Appl Physiol 1981;51:1251–6.
Dodds WJ, Abelseth MK. Criteria for selecting the animal to meet the research need. Lab Anim Sci 1980;30:460–5.
Bengtsson A, Redl H, Paul E, Schlag G, Mollnes TE, Davies J. Complement and leukocyte activation in septic baboons. Circ Shock 1993;39:83–8.
Gasbarrini A, Addolorato G, Di Campli C, et al. Gender affects reperfusion injury in rat liver. Dig Dis Sci 2001;46:1305–12.
Xu K, Sun X, Puchowicz MA, LaManna JC. Increased sensitivity to transient global ischemia in aging rat brain. Adv Exp Med Biol 2007;599:199–206.
Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005;2:396–409.
Abe S, Tanaka Y, Fujise N, et al. An antioxidative nutrient-rich enteral diet attenuates lethal activity and oxidative stress induced by lipopolysaccharide in mice. JPEN J Parenter Enteral Nutr 2007;31:181–7.
Russell WMS, Burch RL. The principles of humane experimental technique. London,: Methuen; 1959.
Basu S, Mutschler DK, Larsson AO, Kiiski R, Nordgren A, Eriksson MB. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001;50:341–8.
Lipcsey M, Soderberg E, Basu S, et al. F2-isoprostane, inflammation, cardiac function and oxygenation in the endotoxaemic pig. Prostaglandins Leukot Essent Fatty Acids 2008;78:209–17.
Basu S, Eriksson M. Vitamin E in relation to lipid peroxidation in experimental septic shock. Prostaglandins Leukot Essent Fatty Acids 2000;62:195–9.
Arkovitz MS, Wispe JR, Garcia VF, Szabo C. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 1996;31:1009–15.
Kristof AS, Goldberg P, Laubach V, Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998;158:1883–9.
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.
Remick DG, Newcomb DE, Bolgos GL, Call DR. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 2000:13:110–6.
Reddy RC, Chen GH, Tateda K, et al. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. Am J Physiol Lung Cell Mol Physiol 2001;281:L537–43.
Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 1998;438:159–60.
Basu S, Eriksson M. Lipid peroxidation induced by an early inflammatory response in endotoxaemia. Acta Anaesthesiol Scand 2000;44:17–23.
Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782–7.
Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol 2000;12:13–9.
Beutler B, Poltorak A. Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur Cytokine Netw 2000;11:143–52.
Brightbill HD, Modlin RL. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 2000;101:1–10.
Engstrom Y. Induction and regulation of antimicrobial peptides in Drosophila. Dev Comp Immunol 1999;23:345–58.
Imler JL, Hoffmann JA. Signaling mechanisms in the antimicrobial host defense of Drosophila. Curr Opin Microbiol 2000;3:16–22.
Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999;11:13–8.
Qureshi ST, Gros P, Malo D. Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes. Trends Genet 1999;15:291–4.
Wasserman SA. Toll signaling: the enigma variations. Curr Opin Genet Dev 2000;10:497–502.
Hitchcock PJ, Leive L, Makela PH, Rietschel ET, Strittmatter W, Morrison DC. Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol 1986;166:699–705.
Qureshi N, Takayama K, Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 1991;59:441–4.
Pridmore AC, Wyllie DH, Abdillahi F, et al. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001;183:89–96.
Holst O, Ulmer AJ, Brade H, Flad HD, Rietschel ET. Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol 1996;16:83–104.
Devoe IW, Gilchrist JE. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med 1973;138:1156–67.
Hoekstra D, van der Laan JW, de Leij L, Witholt B. Release of outer membrane fragments from normally growing Escherichia coli. Biochim Biophys Acta 1976;455:889–99.
Jorgensen JH, Smith RF. Measurement of bound and free endotoxin by the Limulus assay. Proc Soc Exp Biol Med 1974;146:1024–31.
Sjolin J, Goscinski G, Lundholm M, Bring J, Odenholt I. Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release. Clin Microbiol Inf 2000;6:74–81.
Cooper NR, Morrison DC. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol 1978;120:1862–8.
Freudenberg MA, Galanos C. Interaction of lipopolysaccharides and lipid A with complement in rats and its relation to endotoxicity. Infect Immun 1978;19:875–82.
Galanos C, Rietschel ET, Luderitz O, Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem 1971;19:143–52.
Vukajlovich SW. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A. Infect Immun 1986;53:480–5.
Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141:547–52.
Kitchens RL. Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol 2000;74:61–82.
Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000;164:5998–6004.
Muzio M, Polentarutti N, Bosisio D, Prahladan MK, Mantovani A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 2000;67:450–6.
Zhang FX, Kirschning CJ, Mancinelli R, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 1999;274:7611–4.
Antal-Szalmas P, Strijp JA, Weersink AJ, Verhoef J, Van Kessel KP. Quantitation of surface CD14 on human monocytes and neutrophils. J Leukoc Biol 1997;61:721–8.
Parker SJ, Watkins PE. Experimental models of gram-negative sepsis. Br J Surg 2001;88:22–30.
Fiorini RN, Shafizadeh SF, Polito C, et al. Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice. American journal of transplantation 2004;4:1567–73.
Giacometti A, Cirioni O, Ghiselli R, et al. Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock. Peptides 2003;24:1747–52.
Goscinski G, Lipcsey M, Eriksson M, Larsson A, Tano E, Sjolin J. Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock. Crit Care 2004;8:R35–R41.
Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 2009;37:S30–7.
Schrauwen E, Cox E, Houvenaghel A. Escherichia coli sepsis and endotoxemia in conscious young pigs. Vet Res Commun 1988;12:295–303.
Crocker SH, Eddy DO, Obenauf RN, Wismar BL, Lowery BD. Bacteremia: host-specific lung clearance and pulmonary failure. J Trauma 1981;21:215–20.
Matejovic M, Krouzecky A, Martinkova V, et al. Effects of tempol, a free radical scavenger, on long-term hyperdynamic porcine bacteremia. Crit Care Med 2005;33:1057–63.
Saetre T, Hoiby EA, Aspelin T, Lermark G, Egeland T, Lyberg T. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit Care Med 2000;28:2697–706.
Hubbard WJ, Choudhry M, Schwacha MG, et al. Cecal ligation and puncture. Shock 2005;24 Suppl 1:52–7.
Zapelini PH, Rezin GT, Cardoso MR, et al. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion 2008;8:211–8.
Devrim E, Avci A, Erguder IB, Karagenc N, Kulah B, Durak I. Activities of xanthine oxidase and superoxide dismutase enzymes in rat intestinal tissues in sepsis. J Trauma 2008;64:733–5.
Neumann B, Zantl N, Veihelmann A, et al. Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int Immunol 1999;11:217–27.
Zantl N, Uebe A, Neumann B, et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998;66:2300–9.
Rodriguez ZZ, Guanche D, Alvarez RG, Rosales FH, Alonso Y, Schulz S. Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis. Inflamm Res 2009.
Goldfarb RD, Glock D, Kumar A, et al. A porcine model of peritonitis and bacteremia simulates human septic shock. Shock 1996;6:442–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lipcsey, M., Eriksson, M., Basu, S. (2011). Oxidative Stress in Animal Models with Special Reference to Experimental Porcine Endotoxemia. In: Basu, S., Wiklund, L. (eds) Studies on Experimental Models. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-956-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-60761-956-7_23
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-955-0
Online ISBN: 978-1-60761-956-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)